David Campbell
Directeur/Membre du Conseil chez SYNAIRGEN PLC
Fortune : 29 170 $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| William Rosenberg | M | - |
iQur Ltd.
 iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 21 ans |
| Phillip Monk | M | 55 | 18 ans | |
| Amanda Radford | F | 53 | 2 ans | |
| Stephen Holgate | M | 77 | 21 ans | |
| Richard Marsden | M | 57 | 21 ans | |
| Joseph Colliver | M | 43 | 1 ans | |
| Brenda Reynolds | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
| Helen Gearing | F | - | 3 ans | |
| Gareth Walters | M | - | 3 ans | |
| Marcin Mankowski | M | - | 1 ans | |
| Richard Francis | M | - | 3 ans | |
| Jody Brooks | F | - | 20 ans | |
| Michael Underwood | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 10 ans |
| Brooke Clarke | F | - | 3 ans | |
| Simon Shaw | M | 59 | 21 ans | |
| John Tite | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 15 ans |
| Simon Holden | M | 48 | - | |
| Felicity Gabbay | M | 72 | 2 ans | |
| Richard Hennings | M | - | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| John Ward | M | 63 | 19 ans | |
| Mike Whelan | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
| Theodora Caroline Harold | F | 50 | 1 ans | |
| Iain Peter Murray Buchanan | M | 72 | 12 ans | |
| Peter Woodford | M | 76 |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
| Paul Hugh Anthony Clegg | M | 64 | 10 ans | |
| Susan Margaret Sundström | F | - | 6 ans | |
| Brent Bartlett | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
| Vic Laville | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Royaume-Uni | 28 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- David Campbell
- Réseau Personnel
